Yuma, Arizona - Right now, Arizona is facing an “Alzheimer’s Epidemic.” 120,000 people are suffering from the debilitating disease and that number will skyrocket in the coming years. But award-wining neurologists Drs. Dean and Ayesha Sherzai a unique husband and wife team on the cutting edge of brain science are zeroing in on Arizona’s communities with a groundbreaking plan to prevent and combat this brain disease.

Washington, DC - Topical treatment with live Roseomonas mucosa, a bacterium naturally present on the skin - was safe for adults and children with atopic dermatitis (eczema) and was associated with reduced disease severity, according to initial findings from an ongoing early-phase clinical trial at the National Institutes of Health. Preclinical work in a mouse model of atopic dermatitis had suggested that R. mucosa strains collected from healthy skin can relieve disease symptoms. The new findings, published May 3 in JCI Insight, support further evaluation of this potential new therapy.

Tucson, Arizona - The University of Arizona College of Medicine - Tucson is launching a medical Spanish training program for residents and fellows to better serve the needs of the city’s Spanish-speaking population.

Rochester, Minnesota - Prescription drug abuse is contributing to the opioid overdose epidemic in the U.S., and the face of addiction is changing.

Tucson, Arizona - The National Rural Health Association has presented Agnes Attakai, MPA, director of health disparities outreach and prevention education at the University of Arizona Mel and Enid Zuckerman College of Public Health, the Rosemary McKenzie Legacy Award for her work as a champion of health equity in Arizona and nationally to reduce health disparities among Arizona’s Native Americans.